Resolution to combat counterfeit pharmaceuticals – american legislative exchange council
WHEREAS, the American Legislative Exchange Council (ALEC) recognizes the significance of protecting ip (IP) legal rights including patented pharmaceuticals no matter national borders and
WHEREAS, protection and enforcement of ip legal rights (IPR) are very important to the way forward for the innovation-based economy and
WHEREAS, ip violation can undermine our national and economic security and
WHEREAS, violations of ip legal rights, ambiguities within the law and insufficient enforcement create uncertainty available on the market and legislation and undermine consumer trust and
WHEREAS, the present Administration released this years Joint Proper Intend on Ip Enforcement highlighting the significance of IPRs towards the U.S. economy and pledging to utilize U.S. buying and selling partners and within worldwide organizations to higher enforce American ip legal rights within the global economy and
WHEREAS, the present Administration promised to initiate an extensive overview of current efforts meant for U.S. companies which have difficulty enforcing their ip legal rights in overseas markets and
WHEREAS, U.S. ip may be worth an believed $5.5 trillion, greater than the GDP associated with a country, and IP-related industries account in excess of 1 / 2 of all U.S. exports, assisting to drive 40% of America’s domestic growth and
WHEREAS, the yearly price of counterfeit pharmaceuticals to consumers and also to pharmaceutical companies, based on the World Health Organization (WHO), this year is going to be $75 billion and
WHEREAS, thousands and thousands of individuals die every year because of counterfeit drugs with no correct active component or accurate dosage and
WHEREAS, under 1 % of counterfeit pharmaceuticals are offered inside the U . s . States, causeing this to be issue an worldwide concern and
WHEREAS, the U.S. Chamber of Commerce highlights the truth that counterfeiting reduces differentiation between products and introduces some risk in to the market and
WHEREAS, protection against counterfeit pharmaceuticals will assist you to improve IP legal rights, allowing companies to compete and thrive within the global economy and
WHEREAS, IP-based industries, for example pharmaceuticals, account in excess of $5 trillion from the U.S. GDP, over 1 / 2 of our exports, and also the employment of 18 million Americans and
WHEREAS, the Anti-Counterfeiting Trade Agreement, a brand new worldwide framework to enforce ip legal rights, looks to become signed this year through the U . s . States, Canada, the Eu, Japan, Mexico, The other agents, Nz, Columbia, Singapore, and Europe
NOW THEREFORE, Whether It Is RESOLVED the commonwealth/condition of [INSERT Condition] supports Government efforts to enhance transparency in ip policy making and through worldwide trade negotiations and
Whether It Is FURTHER RESOLVED the commonwealth/condition of [INSERT Condition] calls around the Departments of Condition and Justice to highlight protection of ip legal rights among its embassy and police force personnel overseas supplying guidance to and enabling these to function as effective advocates and enforcers of ip legal rights and
WHEREAS, the American Legislative Exchange Council (ALEC) recognizes the significance of protecting ip (IP) legal rights including patented pharmaceuticals no matter national borders and
WHEREAS, protection and enforcement of ip legal rights (IPR) are very important to the way forward for the innovation-based economy and
WHEREAS, ip violation can undermine our national and economic security and
WHEREAS, violations of ip legal rights, ambiguities within the law and insufficient enforcement create uncertainty available on the market and legislation and undermine consumer trust and
WHEREAS, the present Administration released this years Joint Proper Intend on Ip Enforcement highlighting the significance of IPRs towards the U.S. economy and pledging to utilize U.S. buying and selling partners and within worldwide organizations to higher enforce American ip legal rights within the global economy and
WHEREAS, the present Administration promised to initiate an extensive overview of current efforts meant for U.S. companies which have difficulty enforcing their ip legal rights in overseas markets and
WHEREAS, U.S. ip may be worth an believed $5.5 trillion, greater than the GDP associated with a country, and IP-related industries account in excess of 1 / 2 of all U.S. exports, assisting to drive 40% of America’s domestic growth and
WHEREAS, the yearly price of counterfeit pharmaceuticals to consumers and also to pharmaceutical companies, based on the World Health Organization (WHO), this year is going to be $75 billion and
WHEREAS, thousands and thousands of individuals die every year because of counterfeit drugs with no correct active component or accurate dosage and
WHEREAS, under 1 % of counterfeit pharmaceuticals are offered inside the U . s . States, causeing this to be issue an worldwide concern and
WHEREAS, the U.S. Chamber of Commerce highlights the truth that counterfeiting reduces differentiation between products and introduces some risk in to the market and
WHEREAS, protection against counterfeit pharmaceuticals will assist you to improve IP legal rights, allowing companies to compete and thrive within the global economy and
WHEREAS, IP-based industries, for example pharmaceuticals, account in excess of $5 trillion from the U.S. GDP, over 1 / 2 of our exports, and also the employment of 18 million Americans and
WHEREAS, the Anti-Counterfeiting Trade Agreement, a brand new worldwide framework to enforce ip legal rights, looks to become signed this year through the U . s . States, Canada, the Eu, Japan, Mexico, The other agents, Nz, Columbia, Singapore, and Europe
NOW THEREFORE, Whether It Is RESOLVED the commonwealth/condition of [INSERT Condition] supports Government efforts to enhance transparency in ip policy making and through worldwide trade negotiations and
Whether It Is FURTHER RESOLVED the commonwealth/condition of [INSERT Condition] calls around the Departments of Condition and Justice to highlight protection of ip legal rights among its embassy and police force personnel overseas supplying guidance to and enabling these to function as effective advocates and enforcers of ip legal rights and
Whether It Is FURTHER RESOLVED the commonwealth/condition of [INSERT Condition] encourages the administration to utilize Congress to enact legislation that expands the IP attaché to additional countries abroad and
Whether It Is FURTHER RESOLVED the commonwealth/condition of [INSERT Condition] calls around the U.S. Fda (Food and drug administration) to make sure that pharmaceutical companies possess the sources they have to implement effective anti-counterfeiting technologies and
Whether It Is FURTHER RESOLVED the commonwealth/condition of [INSERT Condition] commits to making partnerships with likeminded government officials and leaders in countries where counterfeit pharmaceuticals are prevalent in order to combat their proliferation and
Whether It Is FURTHER RESOLVED the commonwealth/condition of [INSERT Condition] invest in dealing with these worldwide partners to facilitate the drafting of laws and regulations that effectively discourage the development and distribution of counterfeit pharmaceuticals which promote consistent enforcement of already established laws and regulations and
Whether It Is FURTHER RESOLVED the commonwealth/condition of [INSERT Condition] calls around the Office from the U . s . States Trade Representative to make sure that trade contracts into that the U . s . States enters will safeguard the integrity of pharmaceuticals all over the world and
Whether It Is FURTHER RESOLVED that the copy of the Resolution be given to obama from the U . s . States, towards the Ip Enforcement Coordinator, towards the Secretary of Condition, towards the Attorney General, towards the Secretary of Commerce, towards the Secretary of Homeland Security, towards the U.S. Trade Representative, towards the Director from the FBI, and also to the Director from the U . s . States Patent and Trademark Office.
Re-Authorized by the ALEC Board of Company directors: September 3, 2019
Resourse: https://alec.org/model-policy/resolution-to-combat-counterfeit-pharmaceuticals/
